These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


337 related items for PubMed ID: 20179099

  • 1. H-, N- and Kras cooperatively regulate lymphatic vessel growth by modulating VEGFR3 expression in lymphatic endothelial cells in mice.
    Ichise T, Yoshida N, Ichise H.
    Development; 2010 Mar; 137(6):1003-13. PubMed ID: 20179099
    [Abstract] [Full Text] [Related]

  • 2. Sox18 induces development of the lymphatic vasculature in mice.
    François M, Caprini A, Hosking B, Orsenigo F, Wilhelm D, Browne C, Paavonen K, Karnezis T, Shayan R, Downes M, Davidson T, Tutt D, Cheah KS, Stacker SA, Muscat GE, Achen MG, Dejana E, Koopman P.
    Nature; 2008 Dec 04; 456(7222):643-7. PubMed ID: 18931657
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.
    Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, Betsholtz C, Alitalo K.
    Nat Immunol; 2004 Jan 04; 5(1):74-80. PubMed ID: 14634646
    [Abstract] [Full Text] [Related]

  • 4. Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor 3 signaling.
    Taniguchi K, Kohno R, Ayada T, Kato R, Ichiyama K, Morisada T, Oike Y, Yonemitsu Y, Maehara Y, Yoshimura A.
    Mol Cell Biol; 2007 Jun 04; 27(12):4541-50. PubMed ID: 17438136
    [Abstract] [Full Text] [Related]

  • 5. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
    Qin TT, Xu GC, Qi JW, Yang GL, Zhang K, Liu HL, Xu LX, Xiang R, Xiao G, Cao H, Wei Y, Zhang QZ, Li LY.
    J Pathol; 2015 Nov 04; 237(3):307-18. PubMed ID: 26096340
    [Abstract] [Full Text] [Related]

  • 6. Ets family members induce lymphangiogenesis through physical and functional interaction with Prox1.
    Yoshimatsu Y, Yamazaki T, Mihira H, Itoh T, Suehiro J, Yuki K, Harada K, Morikawa M, Iwata C, Minami T, Morishita Y, Kodama T, Miyazono K, Watabe T.
    J Cell Sci; 2011 Aug 15; 124(Pt 16):2753-62. PubMed ID: 21807940
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.
    Ochi N, Matsuo Y, Sawai H, Yasuda A, Takahashi H, Sato M, Funahashi H, Okada Y, Manabe T.
    Pancreas; 2007 May 15; 34(4):444-51. PubMed ID: 17446844
    [Abstract] [Full Text] [Related]

  • 8. Sumoylation of Prox1 controls its ability to induce VEGFR3 expression and lymphatic phenotypes in endothelial cells.
    Pan MR, Chang TM, Chang HC, Su JL, Wang HW, Hung WC.
    J Cell Sci; 2009 Sep 15; 122(Pt 18):3358-64. PubMed ID: 19706680
    [Abstract] [Full Text] [Related]

  • 9. Ras/MAPK signaling modulates VEGFR-3 expression through Ets-mediated p300 recruitment and histone acetylation on the Vegfr3 gene in lymphatic endothelial cells.
    Ichise T, Yoshida N, Ichise H.
    PLoS One; 2012 Sep 15; 7(12):e51639. PubMed ID: 23284731
    [Abstract] [Full Text] [Related]

  • 10. Lymphatic ontogeny and effect of hypoplasia in developing lung.
    Kulkarni RM, Herman A, Ikegami M, Greenberg JM, Akeson AL.
    Mech Dev; 2011 Sep 15; 128(1-2):29-40. PubMed ID: 20932899
    [Abstract] [Full Text] [Related]

  • 11. Inhibiting tumor growth of colorectal cancer by blocking the expression of vascular endothelial growth factor receptor 3 using interference vector-based RNA interference.
    Lui Z, Ma Q, Wang X, Zhang Y.
    Int J Mol Med; 2010 Jan 15; 25(1):59-64. PubMed ID: 19956902
    [Abstract] [Full Text] [Related]

  • 12. Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) on monocytic bone marrow-derived cells in the conjunctiva.
    Hamrah P, Chen L, Cursiefen C, Zhang Q, Joyce NC, Dana MR.
    Exp Eye Res; 2004 Oct 15; 79(4):553-61. PubMed ID: 15381039
    [Abstract] [Full Text] [Related]

  • 13. Development of a new method for isolation and long-term culture of organ-specific blood vascular and lymphatic endothelial cells of the mouse.
    Yamaguchi T, Ichise T, Iwata O, Hori A, Adachi T, Nakamura M, Yoshida N, Ichise H.
    FEBS J; 2008 May 15; 275(9):1988-98. PubMed ID: 18355322
    [Abstract] [Full Text] [Related]

  • 14. VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis.
    Zhang L, Zhou F, Han W, Shen B, Luo J, Shibuya M, He Y.
    Cell Res; 2010 Dec 15; 20(12):1319-31. PubMed ID: 20697430
    [Abstract] [Full Text] [Related]

  • 15. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.
    Veikkola T, Jussila L, Makinen T, Karpanen T, Jeltsch M, Petrova TV, Kubo H, Thurston G, McDonald DM, Achen MG, Stacker SA, Alitalo K.
    EMBO J; 2001 Mar 15; 20(6):1223-31. PubMed ID: 11250889
    [Abstract] [Full Text] [Related]

  • 16. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis.
    He Y, Rajantie I, Ilmonen M, Makinen T, Karkkainen MJ, Haiko P, Salven P, Alitalo K.
    Cancer Res; 2004 Jun 01; 64(11):3737-40. PubMed ID: 15172976
    [Abstract] [Full Text] [Related]

  • 17. Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells.
    Zhuo W, Luo C, Wang X, Song X, Fu Y, Luo Y.
    J Pathol; 2010 Nov 01; 222(3):249-60. PubMed ID: 20814900
    [Abstract] [Full Text] [Related]

  • 18. Methods to study lymphatic vessel integrins.
    Garmy-Susini B, Makale M, Fuster M, Varner JA.
    Methods Enzymol; 2007 Nov 01; 426():415-38. PubMed ID: 17697894
    [Abstract] [Full Text] [Related]

  • 19. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
    Zeng Y, Opeskin K, Goad J, Williams ED.
    Cancer Res; 2006 Oct 01; 66(19):9566-75. PubMed ID: 17018613
    [Abstract] [Full Text] [Related]

  • 20. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody.
    Pytowski B, Goldman J, Persaud K, Wu Y, Witte L, Hicklin DJ, Skobe M, Boardman KC, Swartz MA.
    J Natl Cancer Inst; 2005 Jan 05; 97(1):14-21. PubMed ID: 15632376
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.